Literature DB >> 3543419

Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy.

J E Wennberg, N Roos, L Sola, A Schori, R Jaffe.   

Abstract

Data maintained by medical insurance plans can be used to evaluate the incidence of death and nonfatal complications following medical care, to test hypotheses about the outcomes of care, and to identify hospitals with unusually high or low death rates. These uses are illustrated for prostatectomy, utilizing claims data from the Maine Medicare and Manitoba Health Services Commission files. The study shows important differences in death rates between individual hospitals and higher cumulative probability of reoperation following transurethral compared with open prostatectomy. The advantages of claims data are low cost, ease of patient follow-up over long periods, and the absence of reporting bias. The limitations are the adequacy of the data used to control for patient comorbidity and the lack of outcome information on functional status. The effective use of claims data for monitoring requires the active participation of physicians in improving the data base and interpreting the findings.

Entities:  

Mesh:

Year:  1987        PMID: 3543419

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  56 in total

Review 1.  Volume of clinical activity in hospitals and healthcare outcomes, costs, and patient access.

Authors:  A Sowden; V Aletras; M Place; N Rice; A Eastwood; R Grilli; B Ferguson; J Posnett; T Sheldon
Journal:  Qual Health Care       Date:  1997-06

Review 2.  Methodological challenges in studying recurrence of low back pain.

Authors:  Radoslaw Wasiak; Glenn S Pransky; Barbara S Webster
Journal:  J Occup Rehabil       Date:  2003-03

Review 3.  Review of current and future approaches to the management of benign prostatic hyperplasia.

Authors:  J C Gingell
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

4.  Outcomes and the management of health care. Health Services Research Group.

Authors: 
Journal:  CMAJ       Date:  1992-12-15       Impact factor: 8.262

5.  Variations in the quality of care at radical prostatectomy.

Authors:  Quoc-Dien Trinh; Jesse Sammon; Jay Jhaveri; Maxine Sun; Khurshid R Ghani; Jan Schmitges; Wooju Jeong; James O Peabody; Pierre I Karakiewicz; Mani Menon
Journal:  Ther Adv Urol       Date:  2012-04

Review 6.  Comparative hospital databases: value for management and quality.

Authors:  R Cleary; R Beard; J Coles; B Devlin; A Hopkins; D Schumacher; I Wickings
Journal:  Qual Health Care       Date:  1994-03

7.  What can Europeans learn from Americans?

Authors:  A C Enthoven
Journal:  Health Care Financ Rev       Date:  1989-12

8.  Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial.

Authors:  A S Bdesha; C J Bunce; J P Kelleher; M E Snell; J Vukusic; R O Witherow
Journal:  BMJ       Date:  1993-05-15

9.  Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.

Authors:  Dong-Churl Suh; Stephen Arcona; Simu K Thomas; Christopher Powers; Adrian L Rabinowicz; Hyunchul Shin; Dario Mirski
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Are PRO discharge screens associated with postdischarge adverse outcomes?

Authors:  F Wei; D Mark; A Hartz; C Campbell
Journal:  Health Serv Res       Date:  1995-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.